Abstract

Male infertility is a prevalent condition, affecting 5-10% of men. So far, few genetic factors have been described as contributors to spermatogenic failure. Here, we report the first re-sequencing study of the Y-chromosomal Azoospermia Factor c (AZFc) region, combined with gene dosage analysis of the multicopy DAZ, BPY2, and CDYgenes and Y-haplogroup determination. In analysing 2324 Estonian men, we uncovered a novel structural variant as a high-penetrance risk factor for male infertility. The Y lineage R1a1-M458, reported at >20% frequency in several European populations, carries a fixed ~1.6 Mb r2/r3 inversion, destabilizing the AZFc region and predisposing to large recurrent microdeletions. Such complex rearrangements were significantly enriched among severe oligozoospermia cases. The carrier vs non-carrier risk for spermatogenic failure was increased 8.6-fold (p=6.0×10-4). This finding contributes to improved molecular diagnostics and clinical management of infertility. Carrier identification at young age will facilitate timely counselling and reproductive decision-making.

Highlights

  • The diagnosis of male factor infertility due to abnormal semen parameters concerns ~10% of men (Jungwirth et al, 2012; Datta et al, 2016)

  • A statistically significant excess of gr/gr deletions was detected in idiopathic male infertility patients (2.7%; n = 32/ 1190) compared to reference cases (1.2%; n = 14/1134) (Fisher’s exact test, p=0.016; odds ratio [OR] = 2.2 [95% confidence interval (CI) 1.2–4.2]) (Figure 1D, Supplementary file 2)

  • We conducted a comprehensive investigation of partial deletion subtypes of the Y-chromosomal Azoospermia Factor c (AZFc) region in 2324 Estonian men, approximately half with idiopathic spermatogenic impairment (n = 1190) in comparison to the reference group (n = 1134)

Read more

Summary

Introduction

The diagnosis of male factor infertility due to abnormal semen parameters concerns ~10% of men (Jungwirth et al, 2012; Datta et al, 2016). The most widely considered genetic factors are karyotype abnormalities (up to 17% of patients) and recurrent de novo microdeletions of the Y-chromosomal Azoospermia Factor a (AZFa) (~0.8 Mb), AZFb (~6.2 Mb), and AZFc (~3.5 Mb) regions (2–10%) (Punab et al, 2017; Olesen et al, 2017; Tuttelmann et al, 2011). For more than 15 years, testing for AZF deletions has been strongly recommended in the diagnostic workup for infertility patients with sperm concentration of

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call